How Does the Knowledge Gap Worsen Over Time?
Seeking Money from Investors
Patent Analytics and Competition
Outside of Law
Broad Patent Claim
Determining Likelihood of Confusion
What to Do When First Selecting a Mark
Assessing Executive Experience
How to Fix the Knowledge Gap
What Does an Audit Action Sheet Look Like?
Budgeting for Drafting and Prosecution
Joint Ventures and Dispute Resolution
When to Do a Freedom to Operate
BioSimilar Patenting Litigation Involving Large Amounts of Money
Cost/Value Curve of Patent a Portfolio
Open Source Software
Limiting Issues Defined in District Court
Get Your Assignments Straight - Contribution of Owners
What Makes Schwegman, Lundberg & Woessner Different?
A Better Way to Allocate Patent Application Budgets
What Engineers Can Learn from Patent Profile Analytics
Biologics vs Small Molecules
Why Should Claims Not Be Read on the Prior Art?
Patent Profile Analytics and Managers
"Who" - Audit Action Sheet
What Do I Give up in Getting My Patent?
Rewards of the Practice
Patent Portfolio and Budgets/Spending
What is a BioSimilar Product Under US Law?
Qualifying for a Patent
Types of Intellectual Property Protection
4 Ways to Prepare your Patent Portfolio for Battle.
Practicing an Invention
Intent of Patent Laws
Common Reasons Trademarks Are Rejected
How is Open Source Incorporated into Software?
Claim Maps and BioSimilars
Purposes of a Trademark
Goal of a Value-Driven Patent Portfolio
Freedom To Operate
What is a Trademark?
Should IP be Part of Our Business Plan?
Standard for Getting a Patent
Ideal Patent Strategy
"How Much" - Audit Action Sheet
Importance of Getting a Patent
Patent Profile Analytics and Researchers
Schwegman Lundberg & Woessner & Post Grant Trial Practice
Factors That Make a Patent Valuable
Do Narrow Patents Add Value to a Portfolio?
Joint Venture Pitfalls
Am I Required to Search for Prior Art?
Inter Partes Review
Prior Art and Rejections
5 Year View Point
What Doesn't a Patent Provide?
How Long Does an FTO Take?
Rebutting a Merely Descriptive Refusal
Considerations Before Hiring IP Council
Requirements to Receive a Patent
Trademark Filing Considerations
Why Do You Enjoy Being a Lawyer?
PTAB Timing Trial Dynamics
Important Attributes to Being a Successful Patent Lawyer
Value Management and Risk Management
How Do Patent Portfolio Values Become Concentrated over Time?
Golden Rule of Auditing a Patent Portfolio
Discovering Annuity Information
Evaluation Agreement and Computer Codes
Steps to Obtaining a Patent
Patent Examination Process
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Post-Grant Proceedings and Patent Enforcement
Different Parts of a Patent Document
FDA Guidelines for Demonstrating Biosimilarity
Consequences of Disclosing Confidential Information
Patents and Other Forms of Intellectual Property Protection
How to Navigate BioSimilar Challenges
Common Law Trademark Rights
Low Risk Joint Ventures
"Whens" - Audit Action Sheet
Open Source Initiative
How do Patent Prosecution Services Vary in Value?
Auction Audit Sheet - Key Issues to Address
Merely Descriptive Refusal
Freedom to Operate
Are BioSimilars Being Approved in the US?
Calculating New Investments
Proper Way to Use a Trademark
First Item on IP To-Do List
OSS Licensing Conditions
How Much Does it Cost to Get a Patent?
Provisional vs Non-Provisional Patent
First Step in Performing a Patent Portfolio Audit
Third Party Confidentiality
Meet Mark Stignani
"Claims" of a Patent
The Different Types of Marks
Intellectual Property Protection
Engineers Not Understanding Patents
Repeating Competitor Audits
Impact of US Hatch Waxman Act 1984
Litigation and BioSimilar Patenting
Patent Profile Analytics and Engineers
Segmenting a Portfolio
Benefits of Audit Action Sheet
Inventors and Patent Analytics
What is a Patent?
How is Open Source Software Enforced?
NDAs and Computer Codes
NDAs and Customers
The Five Components of an Open Source Software Policy
Trade Name Protection and Trademark Protection
Domain Registration Considerations
Secondary Meaning of a Trademark
Cost of Registering a Trademark
Patent Trial and Appeal Board
What IP Should I Spend Money on First?
PTAB Final Argument Trial Dynamics
Naming Problems with BioSimilars
Value Management and Cash Flow
Raising Good Prosecution Visibility
Improperly Marked Product
Tracking Work History
Patent Ownership and Patent Profile Analytics
Forms of Confidential Information
Inventorship vs Ownership
Is There Still a Place for Traditional Re-Examination?
Who Determines Substitution Factors?
Challenges When Dealing with Patent Matters
Tools for Auditing a Patent Portfolio
Researching Competitors' IP
"Whats" - Audit Action Sheet
Renewing a Trademark Registration
Limited Valuable Patents in Technology Area
Reasons to Consider Joint Ventures
Trade Names vs Trademarks
Mitigating Risks of Past Damages
Patent Strategy Considerations
How can OSS Negatively Affect a Company?
Claim Abstraction Theory
Prior Art Challenge
Post-Grant Options and Grounds of Challenge
Why Are Biologicals so Important?
Importance of Post-Grant Proceedings
Impact of Post-Grant Proceedings
Joint Venture Ground Rules
Why Perform Risk Profile?
A Less Expensive Alternative
Factors That Cause a Patent to Decline in Value
How Does the Knowledge Gap Develop?
Equal Value Patents
By the Numbers Overview
Confidential Information and Business Damage
Scope Concepts and Headnotes
Process for Registering a Trademark in the United States
Cost/Value Curve of a High Level Patent
Impact of PTAB
Categories of Marks
Patent Owner Rights
Patents and Practicing an Invention
Value-Driven Patent Portfolio
Picking a Domain Name
Trademarks and Brand Value
Post-Grant Options and Cost
Hiring Patent Council
Independent Claim vs Dependent Claim
Meet David Black
Attorneys and Patent Profile Analytics
Freedom To Operate vs Clearance
What is a Patent Portfolio?
Two Main Value Drivers
Helping In-House Council
Forward Citation Landscape
Approvals of BioSimilars in Europe
How Should IP be Considered for Acquisition?
Why Is Executing an NDA Not Enough?
Is A United States Registered Trademark Effective in Other Countries?
Covered Business Method Review
How is the Entire Patent Considered Prior Art?
Picking a Trademark
Advantages of Registering a Trademark
Moderate Risk Joint Ventures
What is Prior Art?
Unlicensed Source Codes
Infringement on the Rights of Other Patents
Interpretational Differences Between Prosecution and Litigation
Risks of Not Patenting
Demonstrating BioSimilarity Under U.S. Law
Patent Status Updates
"Wheres" - Audit Action Sheet
Becoming a Patent Lawyer
The Case of the Joint Marketing Agreement Gone Bad
Patent Citation Ranking
Risks of OSS
How Big Should My First Patent Be?
High Risk Joint Ventures
Cited Art Landscape
Implementing a Value-Driven Portfolio Process
The Advantage of Filing First
Wasting Money on Low-Value Patents
How to Remedy Unwanted Disclosure of Confidential Information
What is a BioSimilar?
Improving Patent Portfolio Value
Attorneys Not Understanding the Market
Downside of Static Budget Allocation for Patents
Infringing on Another Patent
Portfolio Dashboard - Inventor Information
When is a House like a Patent?
Effective Stay Strategy
Contractual Intellectual Property Rights
Date of First Use
Value Management Lifecycle
Marking a Product
Consequences of a Poorly Drafted Patent
Geographic Insight and Patent Profile Analytics
How is Schwegman Lundberg & Woessner Different?
What is an Invention?
Refused Trademark Recourse
Biologics Price Competition and Innovation Act
Post-Grant Options and Estoppel
Freedom to Operate (FTO) Process
Using Product Association with IP Assets
Audit Action Sheet
Most Common Client Question
What Should a Company Patent?
Joint Venture and Financial Agreements
Prior Art in Prosecution vs Prior Art in Litigation
Signing an NDA
IP Registration Density
Types of Inventions That Are Patentable
Attributes of a Good Patent
Importance of Freedom To Operate
What Should a Company Understand at the End of an IP Audit?
How Should IP be Considered for Growth?